Preclinical combination therapy with gemcitabine and mechanisms of resistance

被引：0
|
作者：
Peters, GJ [1 ]
vanHaperen, VWTR [1 ]
Bergman, AM [1 ]
Veerman, G [1 ]
SmitskampWilms, E [1 ]
vanMoorsel, CJA [1 ]
Kuiper, CM [1 ]
Braakhuis, BJM [1 ]
机构：
[1] FREE UNIV AMSTERDAM HOSP,DEPT OTOLARYNGOL,NL-1007 MB AMSTERDAM,NETHERLANDS
来源：
SEMINARS IN ONCOLOGY | 1996年 / 23卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：16 / 24
页数：9
相关论文
共 50 条
  • [1] Gemcitabine: Preclinical pharmacology and mechanisms of action
    Plunkett, W
    Huang, P
    Searcy, CE
    Gandhi, V
    SEMINARS IN ONCOLOGY, 1996, 23 (05) : 3 - 15
  • [2] Mechanisms, combination therapy, and biomarkers in cancer immunotherapy resistance
    Yang, Manshi
    Cui, Mengying
    Sun, Yang
    Liu, Shui
    Jiang, Weibo
    CELL COMMUNICATION AND SIGNALING, 2024, 22 (01)
  • [3] Docetaxel (Taxotere) and gemcitabine in combination therapy
    Rizvi, NA
    SEMINARS IN ONCOLOGY, 1999, 26 (03) : 19 - 22
  • [4] Preclinical combination chemotherapy of nedaplatin with gemcitabine against gemcitabine-refractory human lung cancer
    Takeda, Y
    Wada, T
    Nishitani, Y
    Matsumoto, M
    Hojo, K
    Maekawa, R
    Yoshioka, T
    CANCER LETTERS, 2002, 182 (01) : 61 - 68
  • [5] Sirolimus Can Reverse Resistance to Gemcitabine, Capecitabine and Docetaxel Combination Therapy in Pancreatic Cancer
    Sherman, William H.
    JOURNAL OF THE PANCREAS, 2009, 10 (04): : 393 - 395
  • [6] A novel therapy for cholangiocarcinoma: Gemcitabine and Tamoxifen combination therapy
    Turk, Amy
    Pawar, Pritish
    Chen, Yabing
    McDonald, Jay
    CANCER RESEARCH, 2009, 69
  • [7] Preclinical evaluation of gemcitabine combination regimens for application in acute myeloid leukemia
    Shanks, RH
    Rizzieri, DA
    Flowers, JL
    Colvin, OM
    Adams, DJ
    CLINICAL CANCER RESEARCH, 2005, 11 (11) : 4225 - 4233
  • [8] PARP inhibitor resistance in breast and gynecological cancer: Resistance mechanisms and combination therapy strategies
    Wang, Nannan
    Yang, Yan
    Jin, Dongdong
    Zhang, Zhenan
    Shen, Ke
    Yang, Jing
    Chen, Huanhuan
    Zhao, Xinyue
    Yang, Li
    Lu, Huaiwu
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [9] Gemcitabine and pemetrexed: novel associations and mechanisms of resistance
    Sablin, Marie-Paule
    Le Tourneau, Christophe
    El Maalouf, Ghassan
    Raymond, Eric
    Faivre, Sandrine
    BULLETIN DU CANCER, 2007, 94 : S149 - S154
  • [10] Leveraging transcriptomic data to pinpoint mechanisms of gemcitabine resistance and potential combination therapies for pancreatic cancer.
    Kusko, Rebecca L.
    Cha, Yoonjeong
    Perez-Rogers, Joseph
    Caballero, Nacho
    Koytiger, Gregory
    Shankar, Jyoti
    Lysaght, Andrew
    Weiner, Brian
    Kolitz, Sarah
    Towfic, Fadi
    Fowler, Kevin
    Vardarajan, Badri
    Artyomov, Maxim
    Zeskind, Benjamin
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345